LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹822 Cr | ₹725 Cr | ₹637 Cr | ₹555 Cr | ₹487 Cr |
What is the latest Total Liabilities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹822 Cr |
| Mar2024 | ₹725 Cr |
| Mar2023 | ₹637 Cr |
| Mar2022 | ₹555 Cr |
| Mar2021 | ₹487 Cr |
How is Total Liabilities of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹822 Cr | 13.30 | |
| Mar2024 | ₹725 Cr | 13.97 | |
| Mar2023 | ₹637 Cr | 14.77 | |
| Mar2022 | ₹555 Cr | 13.81 | |
| Mar2021 | ₹487 Cr | - | |
Compare Total Liabilities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,233.0 Cr | -5.8% | -13.4% | 4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -5.8% |
-13.4% |
4.4% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses